Hologic Statistics
Share Statistics
Hologic has 226.94M shares outstanding. The number of shares has increased by -3.22% in one year.
| Shares Outstanding | 226.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.47% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 223.70M |
| Failed to Deliver (FTD) Shares | 7.71K |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 4.85M, so 2.09% of the outstanding shares have been sold short.
| Short Interest | 4.85M |
| Short % of Shares Out | 2.09% |
| Short % of Float | 2.12% |
| Short Ratio (days to cover) | 3.63 |
Valuation Ratios
The PE ratio is 24.13 and the forward PE ratio is 16.9. Hologic 's PEG ratio is 1.08.
| PE Ratio | 24.13 |
| Forward PE | 16.9 |
| PS Ratio | 4.73 |
| Forward PS | 4 |
| PB Ratio | 3.71 |
| P/FCF Ratio | 16.64 |
| PEG Ratio | 1.08 |
Enterprise Valuation
Hologic Inc. has an Enterprise Value (EV) of 17.22B.
| EV / Earnings | 21.81 |
| EV / Sales | 4.27 |
| EV / EBITDA | 13.29 |
| EV / EBIT | 19.51 |
| EV / FCF | 15.04 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.49.
| Current Ratio | 3.69 |
| Quick Ratio | 3.03 |
| Debt / Equity | 0.49 |
| Total Debt / Capitalization | 33.07 |
| Cash Flow / Debt | 0.51 |
| Interest Coverage | 7.23 |
Financial Efficiency
Return on equity (ROE) is 0.15% and return on capital (ROIC) is 10.34%.
| Return on Equity (ROE) | 0.15% |
| Return on Assets (ROA) | 0.09% |
| Return on Capital (ROIC) | 10.34% |
| Revenue Per Employee | 576.58K |
| Profits Per Employee | 112.95K |
| Employee Count | 6.99K |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.65 |
Taxes
| Income Tax | 75.60M |
| Effective Tax Rate | 0.09 |
Stock Price Statistics
The stock price has increased by 3.75% in the last 52 weeks. The beta is 0.99, so Hologic 's price volatility has been higher than the market average.
| Beta | 0.99 |
| 52-Week Price Change | 3.75% |
| 50-Day Moving Average | 79.45 |
| 200-Day Moving Average | 77.82 |
| Relative Strength Index (RSI) | 35.29 |
| Average Volume (20 Days) | 1.65M |
Income Statement
In the last 12 months, Hologic had revenue of $4.03B and earned $789.50M in profits. Earnings per share was $3.35.
| Revenue | 4.03B |
| Gross Profit | 2.23B |
| Operating Income | 882.60M |
| Net Income | 789.50M |
| EBITDA | 1.30B |
| EBIT | 882.60M |
| Earnings Per Share (EPS) | 3.35 |
Balance Sheet
The company has $2.16B in cash and $2.66B in debt, giving a net cash position of -$497.80M.
| Cash & Cash Equivalents | 2.16B |
| Total Debt | 2.66B |
| Net Cash | -497.80M |
| Retained Earnings | 0 |
| Total Assets | 9.16B |
| Working Capital | 2.79B |
Cash Flow
In the last 12 months, operating cash flow was $1.29B and capital expenditures -$140.20M, giving a free cash flow of $1.15B.
| Operating Cash Flow | 1.29B |
| Capital Expenditures | -140.20M |
| Free Cash Flow | 1.15B |
| FCF Per Share | 4.86 |
Margins
Gross margin is 55.28%, with operating and profit margins of 21.9% and 19.59%.
| Gross Margin | 55.28% |
| Operating Margin | 21.9% |
| Pretax Margin | 21.46% |
| Profit Margin | 19.59% |
| EBITDA Margin | 32.16% |
| EBIT Margin | 21.9% |
| FCF Margin | 28.41% |
Dividends & Yields
HOLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 4.55% |
| FCF Yield | 6.85% |
Analyst Forecast
The average price target for HOLX is $90, which is 22.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $90 |
| Price Target Difference | 22.2% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Stock Splits
The last stock split was on Apr 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 3.7 |
| Piotroski F-Score | 9 |